Skip to content

Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study

Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study - Endovascular therapy using TruePathTM chronic total occlusion device, a multicenter prospective study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026977
Enrollment
150
Registered
2017-05-01
Start date
2017-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infrainguinal symptomatic peripheral artery disease with chronic total occlusion

Interventions

None listed

Sponsors

Kokura Memorial Hospital, Cardiology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Informed consent was done 2)Infrainguinal peripheral artery disease with chronic total occulusion(included in-stent occulusion) 3)Atherosclerotic peripheral artery disease (Rutherford category 2-5) 4)ABI value was less than 0.9 or if the value was more than 0.9, the ischemia of lower limb was confirmed by other modalities. 5)Meet the criteria of EVT 6)More than 20 years old 7)Agreement the clinical follow up.(after procedure, 6 months, 12 months)

Exclusion criteria

Exclusion criteria: 1)Less than 20 years old 2)Pregnancy 3)Stenotc lesions 4)Common femoral artery lesion (If EVT are going to perform for Iliac lesions simultaneously, it allows the study). 5)Planed other clinical study 6)Planed surgical bypass, below/above the knee amputation within 30 days 7)Poor life expectancy 8)Difficulty of antiplatelet therapy, anticoagrant therapy 9)Severe dementia

Design outcomes

Primary

MeasureTime frame
Procedure success (TruePath CTO device cross the target occlusion through to the true distal lumen)

Secondary

MeasureTime frame
Complication Proportion of true lumen using IVUS analysis Procedure time, device using time, fluoroscopy time, dose Improvement of Rutherford category

Countries

Japan

Contacts

Public ContactYusuke Tomoi

Kokura Memorial Hospital Cardiology

mbxtg263@ybb.ne.jp093-511-2000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026